NantBioScience, a biopharmaceutical firm with links to Colorado University, raises $25m and looks for a total $100m.
NantBioScience, a biopharmaceutical with links to Colorado University, has raised $25m according to a filing with the US Securities and Exchange Commission. The filing further reveals that the company is looking to raise a total of $100m.
NantBioScience is a subsidiary of NantWorks, which secured $250m itself in October 2014. In total, the nine NantWorks companies have raised close to half a billion dollars since NantWork’s launch in 2013.
NantBioScience signed a research collaboration agreement with Colorado University in September 2014. The agreement relates to research into Ral proteins, which has been identified as a key factor of tumour growth and metastasis in more than a third of cancers.
No further details about the funding have been disclosed.
